glp 1 in australia More than million Australians were prescribed a GLP-1 obesity medication last year, yet access, funding and clinical pathways remain uneven. IQVIA's new white paper, Hassan Chaudhry examines… The rapid rise in the

10.1093/stmcls/sxad010 Summary Keywords diabetic kidney disease (DKD), sodium-glucose co-transporter 2 inhibitors (SGLT2i), finerenone, gut-kidney axis, cardiorenal protection Citation Zhang H, Wang K, Zhao H, Qin B, Cai X, Wu M, Li J and Wang J (2025) Diabetic kidney disease: from pathogenesis to multimodal therapycurrent evidence and future directions

Pharmaceutical company Eli Lilly launched Mounjaro in 2022, and Zepbound in 2023

With orange juice and a rapid effect

Because Fertility Support is a flavored drink mix rather than a capsule, that trial period also gives users an opportunity to determine whether the format fits comfortably into their daily routine

Goosenberg E et al